Theravance Biopharma Status
The company (NASDAQ: TBPH) reached a definitive agreement to be acquired by Mylan (NASDAQ: MYL) for $265 million on February 2, 2015. Subsequently the deal was cancelled. Previously, the company underwent an initial public offering on NASDAQ stock exchange under the ticer symbol of TBPH on May 16, 2014. The company was spun out off from Theravance Inc.